← Leaderboards
Ashlee D Brunaugh
University Of Texas At Austin
$363,825
Attributed
$363,825
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $300K · FY2019–21$500K$375K$250K$125K$0
'19
'20
'21
Funding mix
By agency
NIH$363,825 · 2
By mechanism
N43$299,995 · 1
F31$63,830 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas At Austin
Same institution · by research overlap
- Reagan R Wetherill$3,003,732
- Jane C Maxwell$815,778
- Adam M Bush$507,301
- R. Dayne Mayfield$12,934,370
- Jonathan Isaac Tamir$507,301
Others in their field
Other Emerging Leaders on “Formulation”
- Matthew Johnson · Duke University$56,071,536
- Susan Abushakra · Alzheon, Inc.$47,690,244
- Xinhua Li · Nano Terra, Inc.$35,520,438
- Nader Fotouhi · Global Alliance For Tb Drug Development$28,468,137
- Jay Evans · University Of Montana$27,950,292
- Kristin Aillon · Midwest Research Institute$24,965,877
Research focus
FormulationTuberculosisPharmaceutical PreparationsCostTuberculosis TreatmentBiologicalBehavioral StudyAerosolsBehaviorCharacteristicsClinical TranslationCohesionAerosolizedCost EffectiveDesignCareerDepositionDetectionDevice DesignsDevicesDoseDrug DevelopmentDrug IndustryCoupled
Grant awards (3)
Pediatric Formulations of Select Second Line Drugs for Treating Tuberculosis$299,995
N43 · FY2021 · AI · contact PI
Optimization of next generation pulmonary dry powder delivery systems$27,779
F31 · FY2020 · HL · contact PI
Optimization of next generation pulmonary dry powder delivery systems$36,051
F31 · FY2019 · HL · contact PI